PitchRound companies meet with investors and potential partners to make deals!
State of SEMDA and the Medtech Industry in the Southeast.
Executive Director, SEMDA
A trip to the hospital and some 22 surgical staples later she was home, but it wasn’t the end of Aimee’s saga. After three days she was rushed to the hospital and it was determined that she had necrotizing fasciitis, a rare flesh-eating bacteria that took nearly took her life and did take both her arms below the elbow, her right leg below the knee, and nearly her entire left leg.
Aimee will share her story and the provide a personal account of the value of medtech innovation.
Our panel will cover the broad strategies for IP protection as a medical device company. We will address IP strategies attractive to venture capital or potential acquirers and the dos and don’ts of IP capital allocation. We will also get into the nuts and bolts of what to protect from an IP standpoint, how and where to protect it, and address strategies for maximizing the value of your portfolio.
DePuy Synthes Biomaterials
BakerHostetler – Moderator
Don Turner has more than two decades of experience commercializing transformative and award winning solutions across numerous industry verticals on a global basis. Don has served in roles such as Chairman of the Board, CEO, COO, and CTO for globally recognized companies, served on the advisory board for Cisco Systems, committee chairman for Massachusetts Biotechnology Council, advisory board member and program director for the new technologies ventures group at Northrup Grumman, lectured at business schools on commercialization and entrepreneurship, spoken at industry conferences on personalized medicine, served on healthcare innovation and investment panels, chaired steering committees, and worked pro bono for several years as a shadow CXO for growth stage companies as a means of giving back.
Marsh & McLennan Agency
BakerHostetler – Moderator
Life Science Nation
Johnson & Johnson Innovation
Tao Life Sciences -Moderator
Partner, HealthQuest Capital
CEO, Visioneering Technologies
King & Spalding
CEO, Dune Medical Devices
Vice President of Sales & Marketing, Isoray
Program Director, GCMI and T3 Labs
VP Healthcare, Write2Market – moderator
TMC Innovation Institute – Moderator
The Buy Side
Dr. Jayne Morgan
Drug Innovations Ventures at Emory
PitchRounds Elevator Pitches will provide our PitchRound companies three minutes to share their story in lighting round presentations.
Pitch finalists will be announced.
How does the political landscape influence investment in innovation in the US medtech industry? How has the role of government in the development of new innovative medical devices evolved in recent years? What should the medtech industry be anticipating during this new administration transition period? This panel will provide insight on federal policies, processes, programs that support innovation and entrepreneurship in the medtech sector, as well as advice on working with government and political leaders to accelerate industry growth.
Acting Director, Office of Innovation & Entrepreneurship
US Department of Commerce, EDA
Founder & CEO
Health Connect South
Executive Director & Sr. Vice President
Tiffany Wilson (Moderator)
GCMI & T3 Labs
Arnall Golden Gregory
Linda Braddon – Moderator
Secure BioMed Evaluations
Dr. Omer Inan
Linear Health Sciences
Aron Starosta – Moderator
PitchRounds Winner Announced
Plenary Speaker: Dr. William E. “Billy” Cohn, Vice President, J&J Medical Devices Companies and Director of the Center for Device Innovation, Houston
Prior to joining Johnson & Johnson, Dr. Cohn was Director of the Center for Technology and Innovation and Director of the legendary Cullen Cardiovascular Research Laboratory at the Texas Heart Institute in Houston. Billy is a noted cardiovascular surgeon and visionary serial inventor. He is a Professor of Surgery at Baylor College of Medicine and an Adjunct Professor of Bioengineering at both Rice University and the University of Houston. His major research interests have been focused on decreasing the invasiveness of medical procedures in a wide variety of fields.
Dr. Cohn has been intimately involved in the development of the continuous-flow, totally implantable, artificial heart. In 2011, Dr. Cohn and Dr. O. H. Frazier successfully implanted the first pulseless total heart replacement device in a human patient. Dr. Cohn has a passion for medical device development and has more than 90 US patents granted or pending for his medical innovations that have provided the core technology for six venture-backed medical start-ups.
His numerous awards include an honorary doctorate in science from Oberlin College, the Distinguished Scientist Award, given by the MacDonald Fund, and the Edison Award for excellence in human-centered design and innovation for the SentreHEART® Lariat®. In 2000, Dr. Cohn was named the distinguished Inventor of the Year by the U.S. Intellectual Property Owners Association. In 2014 he was named Outstanding Inventor of the Year by the Houston IPO. In addition, in 2014 he received the Innovation award at ICI in Tel Aviv for inventing the TVA everLINQ system for percutaneous AV fistula creation and for founding TVA Medical. In 2015, he was awarded a Lifetime Achievement Award for healthcare innovation by the Houston Technology Center. Lastly, before joining J&J, he was a Venture Partner at Santé Ventures and was the Chief Medical Officer for BiVACOR USA and for Reliant Heart.
After obtaining an undergraduate degree in Biology and Chemistry from Oberlin College in Ohio, Billy went on to receive his Doctor of Medicine from the Baylor College of Medicine in Houston, Texas. He then completed seven years of general surgical and cardiothoracic surgical training at the Baylor College of Medicine Affiliated Hospitals and a one-year cardiothoracic fellowship at Boston’s Beth Israel Hospital. After completion of his training, he stayed on as a staff Cardiothoracic surgeon at the Beth Israel Deaconess Medical Center and as a full-time faculty of Harvard Medical School for ten years before being recruited back to his hometown of Houston.